Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne

Dermatology

Volumn 198, Issue 2, 1999, Pages 218-222

  Pierard Franchimont C ^a   Henry, F ^a   Fraiture, A L ^a   Fumal, I ^a   Pierard G E ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Acne; Adapalene; Colorimetry; Comedolysis; Squamometry; Tretinoin

Indexed keywords

ADAPALENE; ANTI ACNE AGENT; RETINOIC ACID;

ACNE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMEDO; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FACE; HUMAN; MALE; MORPHOMETRICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN BIOPSY; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADULT; DERMATOLOGIC AGENTS; FACIAL DERMATOSES; HUMANS; KERATOLYTIC AGENTS; MALE; NAPHTHALENES; SINGLE-BLIND METHOD; SKIN; TRETINOIN;

EID: 18744437296     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018117     Document Type: Article

References (33)

1. Kligman AM, Fulton JE. Plewig G: Topical vitamin A acid in acne vulgaris. Arch Dermatol 1969;99:469-476.
2. Webster GF: Topical tretinoin in acne therapy. J Am Acad Dermatol 1998;39:S38-S44.
3. Verschoore M, Langner A, Wolska M, Jablonska S. Czernielewski J: Vehicle controlled study of CD271 lotion in the topical treatment of acne vulgaris. J Invest Dermatol 1993;100: 221.
4. Weiss JS, Shavin JS: Adapalene for the treatment of acne vulgaris. J Am Acad Dermatol 1998;39:S50-S54.
5. Alirezai M, Meynadier J, Jablonska S, Czernielewski J, Verschoore M: Etude comparative de l'efficacité et de la tolérance de gels d'adapalène à 0.1 et 0.3 p. 100 et d'un gel de trétinoïne à 0.025 p. 100 dans le traitement de l'acné. Ann Dermatol Vénéréol 1996; 123:165-170.
6. Shalita A, Weiss JS, Chalker DK, Ellis CN, Greenspan A, Katz HI, Kantor I, Millikan LE, Swinehart T, Swinyer L, Whitmore C, Baker M, Czernielewski J: A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicenter trial. J Am Acad Dermatol 1996;34:482-485.
7. Caron D, Sorba V, Kerrouche N. Clucas A: Split-face comparison of adapalene 0.1% gel and tretinoin 0.025ch gel in acne patients. J Am Acad Dermatol 1997;36:S110-S112.
8. Clucas A, Verschoore M, Sorba V. Poncet M. Baker M, Czernielewski J: Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients. J Am Acad Dermatol 1997; 36:S116-S118.
9. Cunliffe WJ, Caputo R, Dreno B, Förström L, Heenen M, Orfanos CE, Privat Y, Robledo Aguilar A, Meynadier J, Alirezai M, Jablonska S, Shalita A, Weiss JS, Chalker DK, Ellis CN, Greenspan A, Katz HI, Kantor I, Millikan LE, Swinehart JM, Swinyer L, Whitmore C, Czernielewski J, Verschoore M: Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and US multicenter trials. J Am Acad Dermatol 1997;36:S126-S134.
10. Cunliffe WJ, Caputo R, Dreno B, Förström L, Heenen M, Orfanos CE, Privat Y, Robledo Aguilar A, Poncet M, Verschoore M: Efficacy and safety comparison of adapalene (CD271) gel and tretinoin gel in the topical treatment of acne vulgaris. A European multicentre trial. J Dermatol Treat 1997;8:173-178.
11. Dunlap FE, Mills OH, Tuley MR, Baker MD, Plott RT: Adapalene 0.1% gel for the treatment of acne vulgaris: Its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference. Br J Dermatol 1998; 139 (suppl 2):17-22.
12. Grosshans E, Marks R, Mascaro JM, Torras H, Meynadier J, Alirezai M, Finlay AY, Soto P, Poncet M, Verschoore M, Clucas A: Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol 1998;139 (suppl 2):26-33.
13. Galvin SA, Gilbert R, Baker M, Guibal F, Tuley MR: Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations. Br J Dermatol 1998;139(suppl 2):34-40.
14. Cunliffe WJ, Poncet M, Loesche C, Verschoore M: A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: A meta-analysis of five randomized trials. Br J Dermatol 1998;139(suppl 2):48-56.
15. Hjorth N: Indications of vitamin A acid treatment in acne vulgaris. Acta Derm Venereol (Stockh) 1976;55(suppl 74):116-118.
16. Piérard GE, Piérard-Franchimont C: Drugs and cosmetics evaluations with skin strippings; in Maibach H (ed): Dermatologic Research Techniques. Boca Raton, CRC Press, 1996, pp 133-148.
17. Piérard GE, Masson P, Rodrigues L, Berardesca E, Lévêque JL, Loden M, Rogiers V, Sauermann G, Serup J: EEMCO guidance for the assessment of dry skin (xerosis) and ichthyosis: Evaluation by stratum corneum strippings. Skin Res Technol 1996;2:3-11.
18. Holmes RL, Williams M, Cunliffe WJ: Pilosebaceous duct obstruction and acne. Br J Dermatol 1972;87:327-332.
19. Mills OH, Kligman AM: A human model for assaying comedolytic substances. Br J Dermatol 1982;107:543-548.
20. Mills OH, Kligman AM: The follicular biopsy. Dermatologica 1983;167:57-63.
21. Piérard-Franchimont C, Piérard GE: Assessment of aging and actinic damage by cyanoacrylate skin surface strippings. Am J Dermatopathol 1987;9:500-509.
22. Groh DG, Mills OH, Kligman AM: Quantitative assessment of cyanoacrylate follicular biopsies by image analysis. J Soc Cosmet Chem 1992;43:101-112.
23. Pagnoni A, Kligman AM, El Gammal S, Stoudemayer T: Determination of density of follicles on various regions of the face by cyanoacrylate biopsy: Correlation with sebum output. Br J Dermatol 1994;131:862-865.
24. Piérard GE, Piérard-Franchimont C, Goffin V: Digital image analysis of microcomedones. Dermatology 1995;190:99-103.
25. Piérard GE, Nikkels-Tassoudji N, Coffin V, Gaspard U, Slachmuylders P, Lacante P: Acne improvement in young women using a low-dose triphasic oral contraceptive containing gestodene and ethinylestradiol (Tri-Minulet). Interim evaluation of an open, non-controlled clinical study combined with objective biometrological methods. Gynecol Endocrinol 1996;10:S61-S66.
26. Letawe C, Boone M, Piérard GE: Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol 1998;23:56-58.
27. Piérard GE: EEMCO guidance for the assessment of skin colour. J Eur Acad Dermatol Venereol 1998;10:1-11.
28. Piérard GE, Piérard-Franchimont C, Saint Léger D, Kligman AM: Squamometry: The assessment of xerosis by colorimetry of D-Squame adhesive discs. J Soc Cosmet Chem 1992;47:297-305.
29. Piérard GE, Piérard-Franchimont C: Squamometry in acute photodamage. Skin Res Technol 1995;1:137-139.
30. Letawe C, Piérard-Franchimont C, Piérard GE: Squamometry in rating the efficacy of topical corticosteroids in atopic dermatitis. Eur J Clin Pharmacol 1996;51:253-258.
31. Piérard-Franchimont C, Coffin V, Piérard GE: Modulation of human stratum corneum properties by salicylic acid and all-trans-retinoic acid. Skin Pharmacol Appl Skin Physiol 1998;11: 266-272.
32. Lucky AW, Biro FN, Hustar GA, Leach AD, Morrison JA, Ratterman J: Acne vulgaris in premenarchal girls. Arch Dermatol 1994;130: 308-314.
33. Griffiths CEM, Ancian P, Humphries J, Poncet M, Rizova E, Michel S, Clucas A: Adapalene 0.1% gel and adapalene 0.1% cream stimulate retinoic acid receptor mediated gene transcription without significant irritative effects in the skin of healthy human volunteers. Br J Dermatol 1998;139(suppl 2):12-16.